Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Citi
Fuji
Covington
Chubb
Johnson and Johnson
Colorcon
Chinese Patent Office
Moodys

Generated: December 18, 2018

DrugPatentWatch Database Preview

Drug Sales Trends for HUMIRA PEN

« Back to Dashboard

Payment Methods and Pharmacy Types for HUMIRA PEN (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $4,263,300,428
INSIDE ANOTHER STORE $981,368,633
[disabled in preview] $769,474,422
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 988,260
INSIDE ANOTHER STORE 385,218
[disabled in preview] 220,861
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $34,532,276
MEDICARE $977,018,095
[disabled in preview] $5,057,299,085
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for HUMIRA PEN
Drug Units Sold Trends for HUMIRA PEN

Annual Sales Revenues and Units Sold for HUMIRA PEN

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
HUMIRA PEN ➤ Sign Up ➤ Sign Up 2016
HUMIRA PEN ➤ Sign Up ➤ Sign Up 2015
HUMIRA PEN ➤ Sign Up ➤ Sign Up 2014
HUMIRA PEN ➤ Sign Up ➤ Sign Up 2013
HUMIRA PEN ➤ Sign Up ➤ Sign Up 2012
HUMIRA PEN ➤ Sign Up ➤ Sign Up 2011
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Dow
Covington
US Department of Justice
Fuji
McKesson
McKinsey
Cantor Fitzgerald
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.